168 related articles for article (PubMed ID: 34300343)
21. Uniparental disomy and pretreatment IGF-1 may predict elevated IGF-1 levels in Prader-Willi patients on GH treatment.
Palmieri VV; Lonero A; Bocchini S; Cassano G; Convertino A; Corica D; Crinò A; Fattorusso V; Ferraris S; Fintini D; Franzese A; Grugni G; Iughetti L; Lia R; Macchi F; Madeo SF; Matarazzo P; Nosetti L; Osimani S; Pajno R; Patti G; Pellegrin MC; Perri A; Ragusa L; Rutigliano I; Sacco M; Salvatoni A; Scarano E; Stagi S; Tornese G; Trifirò G; Wasniewska M; Fischetto R; Giordano P; Licenziati MR; Delvecchio M;
Growth Horm IGF Res; 2019; 48-49():9-15. PubMed ID: 31487604
[TBL] [Abstract][Full Text] [Related]
22. Long-term effect of growth hormone on sleep-disordered breathing in Malaysian children with Prader-Willi syndrome: a retrospective study.
Tan YT; Azanan MS; Hng SY; Eg KP; Jalaludin MY; Thong MK; Tae SK; Samingan N; Anuar A; Nathan AM
J Clin Sleep Med; 2024 Apr; ():. PubMed ID: 38557309
[TBL] [Abstract][Full Text] [Related]
23. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Frequency and Severity of Sleep-Related Breathing Disorders in Children with Simple Obesity and Paediatric Patients with Prader-Willi Syndrome.
Lecka-Ambroziak A; Wysocka-Mincewicz M; Świercz A; Jędrzejczak M; Szalecki M
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33670584
[TBL] [Abstract][Full Text] [Related]
25. Growth Hormone Treatment for Prader-Willi Syndrome.
Tauber M; Diene G; Molinas C
Pediatr Endocrinol Rev; 2018 Sep; 16(Suppl 1):91-99. PubMed ID: 30378786
[TBL] [Abstract][Full Text] [Related]
26. Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group.
Lindgren AC; Ritzén EM
Acta Paediatr Suppl; 1999 Dec; 88(433):109-11. PubMed ID: 10626558
[TBL] [Abstract][Full Text] [Related]
27. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
[TBL] [Abstract][Full Text] [Related]
28. Ten years with biosimilar rhGH in clinical practice in Sweden - experience from the prospective PATRO children and adult studies.
Lundberg E; Kriström B; Zouater H; Deleskog A; Höybye C
BMC Endocr Disord; 2020 Apr; 20(1):55. PubMed ID: 32349731
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
Angulo M; Castro-Magana M; Mazur B; Canas JA; Vitollo PM; Sarrantonio M
J Pediatr Endocrinol Metab; 1996; 9(3):393-400. PubMed ID: 8887149
[TBL] [Abstract][Full Text] [Related]
30. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
[TBL] [Abstract][Full Text] [Related]
31. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP
J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979
[TBL] [Abstract][Full Text] [Related]
32. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study.
Simon D; Alberti C; Alison M; Le Henaff L; Chevenne D; Boizeau P; Canal A; Ollivier G; Decostre V; Jacqz-Aigrain E; Carel JC; Czernichow P; Hogrel JY
J Clin Endocrinol Metab; 2013 Jul; 98(7):2746-54. PubMed ID: 23626006
[TBL] [Abstract][Full Text] [Related]
33. Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome.
Oto Y; Tanaka Y; Abe Y; Obata K; Tsuchiya T; Yoshino A; Murakami N; Nagai T
Am J Med Genet A; 2014 Mar; 164A(3):671-5. PubMed ID: 24443368
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome.
Donze SH; Damen L; van Alfen-van der Velden JAEM; Bocca G; Finken MJJ; Hoorweg-Nijman GJG; Jira PE; van Leeuwen M; Hokken-Koelega ACS
Clin Endocrinol (Oxf); 2019 Jul; 91(1):118-123. PubMed ID: 30973645
[TBL] [Abstract][Full Text] [Related]
35. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
Goldstone AP; Holland AJ; Butler JV; Whittington JE
Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
[TBL] [Abstract][Full Text] [Related]
36. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
Esen I; Demirel F; Tepe D; Kara O; Koc N
Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of IGF1/IGFBP3 Molar Ratio as an Effective Tool for Assessing the Safety of Growth Hormone Therapy in Small-for-gestational-age, Growth Hormone-Deficient and Prader-Willi Children.
Gaddas M; Périn L; Le Bouc Y
J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):253-261. PubMed ID: 30759961
[TBL] [Abstract][Full Text] [Related]
38. Somatropin therapy in adults with Prader-Willi syndrome.
Höybye C; Thorén M
Treat Endocrinol; 2004; 3(3):153-60. PubMed ID: 16026111
[TBL] [Abstract][Full Text] [Related]
39. Growth and metabolic effects of long-term recombinant human growth hormone (rhGH) treatment in short children born small for gestational age: GH-RAST study.
Labarta JI; de Arriba A; Ferrer M; Loranca M; Martos JM; Rodríguez A; Samaniego ML; Sánchez-Cenizo L
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):923-932. PubMed ID: 32623373
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
